1 2 3 4 5 6 7 8

Regulator of G-Protein Signalling 4 (RGS4) negatively modulates nociceptin/orphanin FQ opioid receptor signalling: Implication for L-Dopa-induced dyskinesia Pisano, C. A.; Mercatelli, D.; Mazzocchi, M.; Brugnoli, A.; Morella, I.; Fasano, S.; Zaveri, N. T.; Brambilla, R.; O'Keeffe, G. W.; Neubig, R. R.; Morari, M. details >> Journal contribution (publication in journal)	BRITISH JOURNAL OF PHARMACOLOGY Vol. 180, No. 7, pp: 927-942, Anno: 2023

Modeling Parkinson's disease in LRRK2 rodents Domenicale, Chiara; Magnabosco, Stefano; Morari, Michele details >> Journal contribution (publication in journal)	NEURONAL SIGNALING Vol. 7, No. 3, pp: 1-23, Anno: 2023

In vivo susceptibility to energy failure parkinsonism and LRRK2 kinase activity Novello, S.; Mercatelli, D.; Albanese, F.; Domenicale, C.; Brugnoli, A.; D'Aversa, E.; Vantaggiato, S.; Dovero, S.; Murtaj, V.; Presotto, L.; Borgatti, M.; Shimshek, D. R.; Bezard, E.; Moresco, R. M.; Belloli, S.; Morari, M. details >> Journal contribution (publication in journal)	NEUROBIOLOGY OF DISEASE Vol. 162, No. January 2022, pp: 105579-1-105579-16, Anno: 2022

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice Domenicale, Chiara; Mercatelli, Daniela; Albanese, Federica; Novello, Salvatore; Vincenzi, Fabrizio; Varani, Katia; Morari, Michele details >> Journal contribution (publication in journal)	BIOMEDICINES Vol. 10, No. 4, pp: 881-1-881-16, Anno: 2022

Modeling Parkinson's disease in LRRK2 mice: Focus on synaptic dysfunction and the autophagylysosomal pathway Albanese, F.; Domenicale, C.; Volta, M.; Morari, M. details >> Journal contribution (publication in journal)	BIOCHEMICAL SOCIETY TRANSACTIONS Vol. 50, No. 1, pp: 621-632, Anno: 2022

Brain injections of glial cytoplasmic inclusions induce a multiple system atrophy-like pathology Teil, Margaux; Dovero, Sandra; Bourdenx, Mathieu; Arotcarena, Marie-Laure; Camus, Sandrine; Porras, Gregory; Thiolat, Marie-Laure; Trigo-Damas, Ines; Perier, Celine; Estrada, Cristina; Garcia-Carrillo, Nuria; Morari, Michele; Meissner, Wassilios G; Herrero, María Trinidad; Vila, Miquel; Obeso, Jose A; Bezard, Erwan; Dehay, Benjamin details >> Journal contribution (publication in journal)	BRAIN Vol. 145, No. 3, pp: 1001-1017, Anno: 2022

Development of a new toolbox for mouse PET-CT brain image analysis fully based on CT images and validation in a PD mouse model Presotto, L; Bettinardi, V; Mercatelli, D; Picchio, M; Morari, M; Moresco, R M; Belloli, Sara details >> Journal contribution (publication in journal)	SCIENTIFIC REPORTS Vol. 12, No. 1, pp: 15822-15832, Anno: 2022

Constitutive silencing of LRRK2 kinase activity leads to early glucocerebrosidase deregulation and late impairment of autophagy in vivo Albanese, F.; Mercatelli, D.; Finetti, L.; Lamonaca, G.; Pizzi, S.; Shimshek, D. R.; Bernacchia, G.; Morari, M. details >> Journal contribution (publication in journal)	NEUROBIOLOGY OF DISEASE Vol. 159, No. 1, pp: 105487-1-105487-13, Anno: 2021

Early dysfunction of substantia nigra dopamine neurons in the parkinq311x mouse Regoni, M.; Zanetti, L.; Comai, S.; Mercatelli, D.; Novello, S.; Albanese, F.; Croci, L.; Consalez, G. G.; Ciammola, A.; Valtorta, F.; Morari, M.; Sassone, J. details >> Journal contribution (publication in journal)	BIOMEDICINES Vol. 9, No. 5, pp: 514-1-514-15, Anno: 2021

Mitochondrial P2X7 Receptor Localization Modulates Energy Metabolism Enhancing Physical Performance Sarti, Alba Clara; Vultaggio-Poma, Valentina; Falzoni, Simonetta; Missiroli, Sonia; Giuliani, Anna Lisa; Boldrini, Paola; Bonora, Massimo; Faita, Francesco; Di Lascio, Nicole; Kusmic, Claudia; Solini, Anna; Novello, Salvatore; Morari, Michele; Rossato, Marco; Wieckowski, Mariusz R; Giorgi, Carlotta; Pinton, Paolo; Di Virgilio, Francesco details >> Journal contribution (publication in journal)	FUNCTION Vol. 2, No. 2, pp: zqab005-1-zqab005-15, Anno: 2021

LRRK2 G2019S kinase activity triggers neurotoxic NSF aggregation Pischedda, F.; Cirnaru, M. D.; Ponzoni, L.; Sandre, M.; Biosa, A.; Carrion, M. P.; Marin, O.; Morari, M.; Pan, L.; Greggio, E.; Bandopadhyay, R.; Sala, M.; Piccoli, G. details >> Journal contribution (publication in journal)	BRAIN Vol. 144, No. 5, pp: 1509-1525, Anno: 2021

L-DOPA promotes striatal dopamine release through D1 receptors and reversal of dopamine transporter Viaro, R.; Longo, F.; Vincenzi, F.; Varani, K.; Morari, M. details >> Journal contribution (publication in journal)	BRAIN RESEARCH Vol. 1768, No. 1, pp: 147583-1-147583-7, Anno: 2021

6-Hydroxydopamine lesion and levodopa treatment modify the effect of buspirone in the substantia nigra pars reticulata Vegas-Suarez, S.; Pisano, C. A.; Requejo, C.; Bengoetxea, H.; Lafuente, J. V.; Morari, M.; Miguelez, C.; Ugedo, L. details >> Journal contribution (publication in journal)	BRITISH JOURNAL OF PHARMACOLOGY Vol. 177, No. 17, pp: 3957-3974, Anno: 2020

Targeting synapse dysfunction in Parkinson's disease Morari, M details >> Attività collegate alla Ricerca	Anno: 2020

Safinamide inhibits in vivo glutamate release in a rat model of Parkinson's disease Pisano, C. A.; Brugnoli, A.; Novello, S.; Caccia, C.; Keywood, C.; Melloni, E.; Vailati, S.; Padoani, G.; Morari, M. details >> Journal contribution (publication in journal)	NEUROPHARMACOLOGY Vol. 167, No. 1 May 2020, pp: 108006-1-108006-8, Anno: 2020

Translation Imaging in Parkinson’s Disease: Focus on Neuroinflammation Belloli, Sara; Morari, Michele; Murtaj, Valentina; Valtorta, Silvia; Moresco, Rosa Maria; Gilardi, Maria Carla details >> Journal contribution (publication in journal)	FRONTIERS IN AGING NEUROSCIENCE Vol. 12, No. 5 June 2020, pp: 152-1-152-16, Anno: 2020

Discovery and Structure-Activity Relationships of Nociceptin Receptor Partial Agonists That Afford Symptom Ablation in Parkinson's Disease Models Kamakolanu, U. G.; Meyer, M. E.; Yasuda, D.; Polgar, W. E.; Marti, M.; Mercatelli, D.; Pisano, C. A.; Brugnoli, A.; Morari, M.; Zaveri, N. T. details >> Journal contribution (publication in journal)	JOURNAL OF MEDICINAL CHEMISTRY Vol. 63, No. 5, pp: 2688-2704, Anno: 2020

Striatal and nigral muscarinic type 1 and type 4 receptors modulate levodopa-induced dyskinesia and striato-nigral pathway activation in 6-hydroxydopamine hemilesioned rats Brugnoli, A.; Pisano, C. A.; Morari, M. details >> Journal contribution (publication in journal)	NEUROBIOLOGY OF DISEASE Vol. 144, No. 1, pp: 105044-1-105044-13, Anno: 2020

Pharmacological antagonism of kainate receptor rescues dysfunction and loss of dopamine neurons in a mouse model of human parkin-induced toxicity Regoni, M.; Cattaneo, S.; Mercatelli, D.; Novello, S.; Passoni, A.; Bagnati, R.; Davoli, E.; Croci, L.; Consalez, G. G.; Albanese, F.; Zanetti, L.; Passafaro, M.; Serratto, G. M.; Di Fonzo, A.; Valtorta, F.; Ciammola, A.; Taverna, S.; Morari, M.; Sassone, J. details >> Journal contribution (publication in journal)	CELL DEATH & DISEASE Vol. 11, No. 11, pp: 963-1-963-11, Anno: 2020

Managing Parkinson's disease: moving ON with NOP Mercatelli, Daniela; Bezard, Erwan; Eleopra, Roberto; Zaveri, Nurulain T; Morari, Michele details >> Journal contribution (publication in journal)	BRITISH JOURNAL OF PHARMACOLOGY Vol. 177, No. 1, pp: 28-47, Anno: 2020